Sonorous Neurovascular

Sonorous Neurovascular (Sonorous NV) is a medical device company focused on innovative treatments for symptomatic cerebral venous diseases, particularly those linked to venous sinus stenosis. The company has developed the BossStent, a single-use, implantable endoluminal prosthesis that aims to normalize blood flow and pressure gradients in cerebral venous sinuses. This device addresses conditions such as pulsatile tinnitus, idiopathic intracranial hypertension (IIH), and papilledema. The BossStent has been utilized in initial clinical cases in North America, demonstrating excellent results. Sonorous NV plans to initiate clinical trials in the European Union and the United States in 2023, with the goal of obtaining regulatory approvals by early 2024. Additionally, the company is pursuing patent protection for advanced self-expanding braided stents designed to treat pulsatile tinnitus. Sonorous NV serves hospitals, neurosurgeons, and interventional specialists, providing advanced, minimally invasive therapeutic options to enhance patient outcomes in the field of cerebral venous disorders.

• Employees 4